|
|
||||||||
Clinical Chemistry, Vol 37, 1405-1411, Copyright © 1991 by American Association for Clinical Chemistry
W Gerhardt, H Katus, J Ravkilde, C Hamm, PJ Jorgensen, E Peheim, L Ljungdahl and P Lofdahl
Department of Clinical Chemistry, Helsingborg, Sweden.
In a multicenter study we compared three tests for ischemic myocardial injury (IMI): a new, automated enzyme immunoassay for S-troponin T (S- TNT; Boehringer Mannheim) and two S-creatine kinase (CK) isoenzyme MB assays (mass and catalytic concentrations). For critical evaluation of clinical sensitivity, we studied 243 cases with an IMI prevalence of 43% and an 18% prevalence of cases with unstable angina. Relative peak values of S-TNT and S-CK-MB (mass) after onset of pain were four- to fivefold higher than S-CK-MB (catalytic) results. Increases of S-TNT and S-CK-MB (mass), even though still within their reference ranges, indicated minor myocardial damage in about one-third of the cases primarily classified as unstable angina. The diagnostic window for S- TNT ranged from hours to weeks after the acute episode. The time courses were frequently biphasic, with the initial S-TNT peak closely paralleling that of the mass concentrations of S-CK-MB. With a biological half-life for S-TNT of 2 h, the prolonged increases in S-TNT indicate a continuous release of S-TNT from necrotizing cells. Clinical specificities of S-TNT and S-CK-MB (mass) were greater than that of S- CK-MB (catalytic), even in the presence of 30% to 40% severe skeletal muscle injuries. The combination of S-TNT and S-CK-MB (mass) is excellent for detection of acute IMI, including minor myocardial damage.
The following articles in journals at HighWire Press have cited this article:
![]() |
C. W. Hamm, H. Möllmann, J.-P. Bassand, and F. van de Werf CHAPTER 16 Acute Coronary Syndromes ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D White Evolution of the definition of myocardial infarction: what are the implications of a new universal definition? Heart, June 1, 2008; 94(6): 679 - 684. [Full Text] [PDF] |
||||
![]() |
P O Collinson, D C Gaze, K Bainbridge, F Morris, B Morris, A Price, and S Goodacre Utility of admission cardiac troponin and "Ischemia Modified Albumin" measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg. Med. J., April 1, 2006; 23(4): 256 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Wang, C.-F. Feng, T.-K. Er, L.-Y. Tsai, C.-Y. Chen, S.-J. Chang, and B.-H. Chen Comparison of Cardiac Troponin I Levels in Serum and Sodium-Citrate Plasma Using the ACCESS 2 Immunoassay Ann. Clin. Lab. Sci., October 1, 2005; 35(4): 453 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rej Clinical Chemistry through Clinical Chemistry: A Journal Timeline Clin. Chem., December 1, 2004; 50(12): 2415 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
P O Collinson, P J Stubbs, and A-C Kessler Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice Heart, March 1, 2003; 89(3): 280 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cerutti, L. Corsini, R. Finotto, and C. Perazzi Comparison of Cardiac Troponin I in Serum and Heparin Plasma with the Dimension RxL Assay Clin. Chem., May 1, 2002; 48(5): 790 - 791. [Full Text] [PDF] |
||||
![]() |
N.J. Alp, J.A. Bell, and M. Shahi A rapid troponin-I-based protocol for assessing acute chest pain QJM, December 1, 2001; 94(12): 687 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Heidenreich, T. Alloggiamento, K. Melsop, K. M. McDonald, A. S. Go, and M. A. Hlatky The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis J. Am. Coll. Cardiol., August 1, 2001; 38(2): 478 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Venge, B. Lindahl, and L. Wallentin New Generation Cardiac Troponin I Assay for the Access Immunoassay System Clin. Chem., May 1, 2001; 47(5): 959 - 961. [Full Text] [PDF] |
||||
![]() |
A. S. Jaffe, J. Ravkilde, R. Roberts, U. Naslund, F. S. Apple, M. Galvani, and H. Katus It's Time for a Change to a Troponin Standard Circulation, September 12, 2000; 102(11): 1216 - 1220. [Full Text] [PDF] |
||||
![]() |
C. A. Labarrere, D. R. Nelson, C. J. Cox, D. Pitts, P. Kirlin, and H. Halbrook Cardiac-Specific Troponin I Levels and Risk of Coronary Artery Disease and Graft Failure Following Heart Transplantation JAMA, July 26, 2000; 284(4): 457 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hamm and E. Braunwald A Classification of Unstable Angina Revisited Circulation, July 4, 2000; 102(1): 118 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Heeschen, B.U. Goldmann, W. Terres, and C.W. Hamm Cardiovascular risk and therapeutic benefit of coronary interventions for patients with unstable angina according to the troponin T status Eur. Heart J., July 2, 2000; 21(14): 1159 - 1166. [Abstract] [PDF] |
||||
![]() |
V. Ricchiuti and F. S. Apple RNA Expression of Cardiac Troponin T Isoforms in Diseased Human Skeletal Muscle Clin. Chem., December 1, 1999; 45(12): 2129 - 2135. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Heeschen, M. J. van den Brand, C. W. Hamm, and M. L. Simoons Angiographic Findings in Patients With Refractory Unstable Angina According to Troponin T Status Circulation, October 5, 1999; 100(14): 1509 - 1514. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Heeschen, B. U. Goldmann, L. Langenbrink, G. Matschuck, and C. W. Hamm Evaluation of a Rapid Whole Blood ELISA for Quantification of Troponin I in Patients with Acute Chest Pain Clin. Chem., October 1, 1999; 45(10): 1789 - 1796. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Lev, J. I. Osende, A. G. Zaman, C. W. Hamm, and C. Heeschen Troponin T Levels and Abciximab Therapy in Unstable Angina N. Engl. J. Med., September 30, 1999; 341(14): 1084 - 1085. [Full Text] |
||||
![]() |
A. H.B. Wu, F. S. Apple, W. B. Gibler, R. L. Jesse, M. M. Warshaw, and R. Valdes Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases Clin. Chem., July 1, 1999; 45(7): 1104 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hamm, C. Heeschen, B. Goldmann, A. Vahanian, J. Adgey, C. M. Miguel, W. Rutsch, J. Berger, J. Kootstra, M. L. Simoons, et al. Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T Levels N. Engl. J. Med., May 27, 1999; 340(21): 1623 - 1629. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Loick, C. Schmidt, H. Van Aken, R. Junker, M. Erren, E. Berendes, N. Rolf, A. Mei{beta}ner, C. Schmid, H. H. Scheld, et al. High Thoracic Epidural Anesthesia, but Not Clonidine, Attenuates the Perioperative Stress Response Via Sympatholysis and Reduces the Release of Troponin T in Patients Undergoing Coronary Artery Bypass Grafting Anesth. Analg., April 1, 1999; 88(4): 701 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ricchiuti, E. M. Voss, A. Ney, M. Odland, P. A. W. Anderson, and F. S. Apple Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim Clin. Chem., September 1, 1998; 44(9): 1919 - 1924. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hamm, B. U. Goldmann, C. Heeschen, G. Kreymann, J. Berger, and T. Meinertz Emergency Room Triage of Patients with Acute Chest Pain by Means of Rapid Testing for Cardiac Troponin T or Troponin I N. Engl. J. Med., December 4, 1997; 337(23): 1648 - 1653. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Luscher, K. Thygesen, J. Ravkilde, and L. Heickendorff Applicability of Cardiac Troponin T and I for Early Risk Stratification in Unstable Coronary Artery Disease Circulation, October 21, 1997; 96(8): 2578 - 2585. [Abstract] [Full Text] |
||||
![]() |
S. E. Lipshultz, N. Rifai, S. E. Sallan, S. R. Lipsitz, V. Dalton, D. B. Sacks, and M. E. Ottlinger Predictive Value of Cardiac Troponin T in Pediatric Patients at Risk for Myocardial Injury Circulation, October 21, 1997; 96(8): 2641 - 2648. [Abstract] [Full Text] |
||||
![]() |
M. Muller-Bardorff, K. Hallermayer, A. Schroder, C. Ebert, A. Borgya, W. Gerhardt, A. Remppis, J. Zehelein, and H. A. Katus Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation Clin. Chem., March 1, 1997; 43(3): 458 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Bodor, L. Survant, E. M. Voss, S. Smith, D. Porterfield, and F. S. Apple Cardiac troponin T composition in normal and regenerating human skeletal muscle Clin. Chem., March 1, 1997; 43(3): 476 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. de Winter, R. W. Koster, J. P. van Straalen, J. P. M. C. Gorgels, F. J. Hoek, and G. T. Sanders Critical difference between serial measurements of CK-MB mass to detect myocardial damage Clin. Chem., February 1, 1997; 43(2): 338 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Lewis and E. A. Amsterdam Evaluation of the Patient With 'Rule Out Myocardial Infarction' Arch Intern Med, January 8, 1996; 156(1): 41 - 45. [Abstract] [PDF] |
||||
![]() |
R. J. de Winter, R. W. Koster, A. Sturk, and G. T. Sanders Value of Myoglobin, Troponin T, and CK-MBmass in Ruling Out an Acute Myocardial Infarction in the Emergency Room Circulation, December 15, 1995; 92(12): 3401 - 3407. [Abstract] [Full Text] |
||||
![]() |
M. Lofberg, R. Tahtela, M. Harkonen, and H. Somer Myosin Heavy-Chain Fragments and Cardiac Troponins in the Serum in Rhabdomyolysis: Diagnostic Specificity of New Biochemical Markers Arch Neurol, December 1, 1995; 52(12): 1210 - 1214. [Abstract] [PDF] |
||||
![]() |
M. Muller-Bardorff, H. Freitag, T. Scheffold, A. Remppis, W. Kubler, and H. A. Katus Development and Characterization of a Rapid Assay for Bedside Determinations of Cardiac Troponin T Circulation, November 15, 1995; 92(10): 2869 - 2875. [Abstract] [Full Text] |
||||
![]() |
M. S. F. Clarke, R. W. Caldwell, H. Chiao, K. Miyake, and P. L. McNeil Contraction-Induced Cell Wounding and Release of Fibroblast Growth Factor in Heart Circ. Res., June 1, 1995; 76(6): 927 - 934. [Abstract] [Full Text] |
||||
![]() |
E. M. Antman, C. Grudzien, and D. B. Sacks Evaluation of a Rapid Bedside Assay for Detection of Serum Cardiac Troponin T JAMA, April 26, 1995; 273(16): 1279 - 1282. [Abstract] [PDF] |
||||
![]() |
C. W. Hamm New Serum Markers for Acute Myocardial Infarction N. Engl. J. Med., September 1, 1994; 331(9): 607 - 608. [Full Text] |
||||
![]() |
R. Seitelberger, W. Hannes, M. Gleichauf, M. Keilich, M. Christoph, R. Fasol, Sponsored by, and E. Wolner Effects of diltiazem on perioperative ischemia, arrhythmias, and myocardial function in patients undergoing elective coronary bypass grafting J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 811 - 821. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |